Concepedia

Enrique Álvarez

EÁ

Statistics

Publications

9

Citations

454

H-Index

9

Active since

1999

Affiliations

Eli Lilly (United States)(Current)

Instituto de Investigaciones Biomédicas Sols-Morreale

Amsterdam UMC Location Vrije Universiteit Amsterdam

Consejo Superior de Investigaciones Científicas

Vrije Universiteit Amsterdam

Enrique Álvarez is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and oncology.

ORCID

Publications per year

1999–2013

9

Publications

9

Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.

Judith R. Kroep, Willem J.P Loves, C.L. van der Wilt et al. · PubMed · 2002 · 191 citations

, , +14

Plitidepsin Has a Dual Effect Inhibiting Cell Cycle and Inducing Apoptosis via Rac1/c-Jun NH2-Terminal Kinase Activation in Human Melanoma Cells

María José Muñoz-Alonso, Laura González-Santiago, Natasha Zarich et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 48 citations

, , +17

MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma.

Beverly A. Teicher, Enrique Álvarez, Liu P et al. · PubMed · 1999 · 43 citations

, , +11

Proteomic Analysis of the Resistance to Aplidin in Human Cancer Cells

Laura González-Santiago, Patricia Alfonso, Yajaira Suárez et al. · Journal of Proteome Research · 2007 · 38 citations

, , +17

Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma

Jo Caers, Eline Menu, Hendrik De Raeve et al. · British Journal of Cancer · 2008 · 35 citations · Full text

, , +17

1–5 of 9